$514 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 123 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TPST | Exit | TEMPEST THERAPEUTICS | $0 | – | -219,394 | -100.0% | -0.05% | – |
| BEAM | Exit | BEAM THERAPEUTICS | $0 | – | -63,500 | -100.0% | -0.34% | – |
| Exit | EQRX INC | $0 | – | -1,135,967 | -100.0% | -0.35% | – | |
| SILK | Exit | SILK ROAD MEDICAL | $0 | – | -80,500 | -100.0% | -0.44% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB | $0 | – | -50,000 | -100.0% | -0.53% | – |
| Exit | ACELYRIN INC | $0 | – | -201,017 | -100.0% | -0.70% | – | |
| Exit | 2SEVENTY BIO INC | $0 | – | -462,485 | -100.0% | -0.78% | – | |
| RETA | Exit | REATA PHARMACEUTICcl a | $0 | – | -47,500 | -100.0% | -0.81% | – |
| GRTX | Exit | GALERA THERAPEUTIC | $0 | – | -2,005,054 | -100.0% | -1.04% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS | $0 | – | -435,313 | -100.0% | -1.12% | – |
| AGLY | Exit | AGILITI INC | $0 | – | -469,277 | -100.0% | -1.29% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -24,000 | -100.0% | -1.30% | – |
| TMCI | Exit | TREACE MED CONCEPT | $0 | – | -379,443 | -100.0% | -1.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.